Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment

Mitochondrial dysfunction represents a central factor within the pathogenesis of the Alzheimer's disease (AD) spectrum. We hypothesized that in vivo measurements of lactate (lac), a by-product of glycolysis, would correlate with functional impairment and measures of brain health in a cohort of 15 amnestic mild cognitive impairment (aMCI) individuals. Lac was quantified from the precuneus/posterior cingulate (PPC) using 2-dimensional J-resolved magnetic resonance spectroscopy (MRS). Additionally, standard behavioral and imaging markers of aMCI disease progression were acquired. PPC lac was negatively correlated with performance on the Wechsler logical memory tests and on the minimental state examination even after accounting for gray matter, cerebral spinal fluid volume, and age. No such relationships were observed between lac and performance on nonmemory tests. Significant negative relationships were also noted between PPC lac and hippocampal volume and PPC functional connectivity. Together, these results reveal that aMCI individuals with a greater disease progression have increased concentrations of PPC lac. Because lac is upregulated as a compensatory response to mitochondrial impairment, we propose that J-resolved MRS of lac is a noninvasive, surrogate biomarker of impaired metabolic function and would provide a useful means of tracking mitochondrial function during therapeutic trials targeting brain metabolism.

[1]  D. Rothman,et al.  What have novel imaging techniques revealed about metabolism in the aging brain? , 2014, Future neurology.

[2]  Vishwanath T. Anekonda,et al.  Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. , 2012, Biochimica et biophysica acta.

[3]  E. Reiman.  Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments , 2011, Neurobiology of Aging.

[4]  J. Franklin,et al.  The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[5]  L. Beason-Held,et al.  Dementia and the default mode. , 2011, Current Alzheimer research.

[6]  M. Corbetta,et al.  Episodic Memory Retrieval, Parietal Cortex, and the Default Mode Network: Functional and Topographic Analyses , 2011, The Journal of Neuroscience.

[7]  V. Marchesi,et al.  Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative‐induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Kaj Blennow,et al.  Biomarkers in Alzheimer's disease drug development , 2010, Nature Medicine.

[9]  Judith E. Hall,et al.  Edited MRS is sensitive to changes in lactate concentration during inspiratory hypoxia , 2010, Journal of magnetic resonance imaging : JMRI.

[10]  Liang Wang,et al.  Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals , 2010, NeuroImage.

[11]  H. Petropoulos,et al.  Improving 1H MRSI measurement of cerebral lactate for clinical applications , 2010, Psychiatry Research: Neuroimaging.

[12]  Pierre J Magistretti,et al.  Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability , 2010, The Journal of Neuroscience.

[13]  Justin L. Vincent,et al.  Precuneus shares intrinsic functional architecture in humans and monkeys , 2009, Proceedings of the National Academy of Sciences.

[14]  M. Obrenovich,et al.  Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. , 2009, The international journal of biochemistry & cell biology.

[15]  Rolf Gruetter,et al.  Neuroprotective Role of Lactate after Cerebral Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[17]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[18]  G. Dienel,et al.  Imaging Brain Activation , 2008, Annals of the New York Academy of Sciences.

[19]  J. Blass.  A New Approach to Treating Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[20]  S. Friedman,et al.  Neuroimaging of mitochondrial disease. , 2008, Mitochondrion.

[21]  R. Rodenburg,et al.  MR spectroscopy of the brain in Leigh syndrome , 2008, Brain and Development.

[22]  R. K. Hutson,et al.  Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment , 2008, Alzheimer's & Dementia.

[23]  J. Baron,et al.  Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[24]  Stefan Posse,et al.  Research Applications of Magnetic Resonance Spectroscopy to Investigate Psychiatric Disorders , 2008, Topics in magnetic resonance imaging : TMRI.

[25]  V. Calhoun,et al.  Selective changes of resting-state networks in individuals at risk for Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.

[26]  D. Rossi,et al.  Astrocyte metabolism and signaling during brain ischemia , 2007, Nature Neuroscience.

[27]  Susan M. Chang,et al.  Three‐dimensional J‐resolved H‐1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T , 2007, Magnetic resonance in medicine.

[28]  Avital Schurr,et al.  Lactate: The Ultimate Cerebral Oxidative Energy Substrate? , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Parvesh Bubber,et al.  Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications , 2005, Annals of neurology.

[30]  J. Perlman,et al.  Hypoxic-ischemic brain injury in the term infant-current concepts. , 2004, Early human development.

[31]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[32]  E. Roberts,et al.  Energy Substrates for Neurons during Neural Activity: A Critical Review of the Astrocyte-Neuron Lactate Shuttle Hypothesis , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  J. Baron,et al.  Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. , 2003, Brain : a journal of neurology.

[34]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[36]  S. Moncada,et al.  Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[38]  E. Cady.  Magnetic resonance spectroscopy in neonatal hypoxic-ischaemic insults , 2001, Child's Nervous System.

[39]  G. Ratcliff,et al.  Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented , 2000, Neurology.

[40]  G H Glover,et al.  Image‐based method for retrospective correction of physiological motion effects in fMRI: RETROICOR , 2000, Magnetic resonance in medicine.

[41]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[42]  J. Frahm,et al.  Alzheimer Disease: Absolute Quantification of Cerebral Metabolites In Vivo Using Localized Proton Magnetic Resonance Spectroscopy , 2000, Alzheimer disease and associated disorders.

[43]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[44]  Godfrey D Pearlson,et al.  Mesial temporal lobe measurements on magnetic resonance imaging scans , 1998, Psychiatry Research: Neuroimaging.

[45]  R. Royall,et al.  Improving sterological estimates for the volume of structures identified in three-dimensional arrays of spatial data , 1997, Journal of Neuroscience Methods.

[46]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[47]  K. Meguro,et al.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[48]  T Ernst,et al.  Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. , 1997, Radiology.

[49]  J A Sorenson,et al.  Localized 2D J‐resolved H MR spectroscopy of human brain tumors in vivo , 1996, Journal of magnetic resonance imaging : JMRI.

[50]  Matthijs Oudkerk,et al.  1H MR Spectroscopy Detection of Lipids and Lactate in Metastatic Brain Tumors , 1996, NMR in biomedicine.

[51]  P. Matthews,et al.  Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. , 1994, Pediatric neurology.

[52]  R. Shulman,et al.  Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[54]  R G Shulman,et al.  Spatially localized 1H NMR spectra of metabolites in the human brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Crane,et al.  Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Law,et al.  Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. , 2009, Clinical radiology.

[57]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[58]  T. Crawford,et al.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. , 2003, AJNR. American journal of neuroradiology.